The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals to develop two agentic AI assistants for ...
Stocktwits on MSN
Travere Therapeutics stock slumps after FDA extends drug review timeline to April: Retail is divided on eventual approval
The timeline extension comes on the heels of the FDA requesting additional information to assess Filspari’s clinical benefit. ・The company submitted responses and the agency determined that the ...
14don MSN
Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program
A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and ...
After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...
14d
Legal questions swirl around FDA's new expedited drug program, including who should give sign off
The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency, stoking worries ...
Investing.com -- Legend Biotech Corp (NASDAQ:LEGN) stock rose 5.7% following the FDA’s release of draft guidance endorsing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results